Cours Iqvia Holdings Inc Nyse
Actions
US74876Y1010
Recherche biotechnologique et médicale
CA 2024 * | 15,49 Md 14,04 Md | CA 2025 * | 16,58 Md 15,03 Md | Capitalisation | 41,73 Md 37,84 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 1,34 Md 1,21 Md | Résultat net 2025 * | 1,58 Md 1,43 Md | VE / CA 2024 * | 3,46 x |
Dette nette 2024 * | 11,83 Md 10,72 Md | Dette nette 2025 * | 11,7 Md 10,61 Md | VE / CA 2025 * | 3,22 x |
PER 2024 * |
31,2
x | PER 2025 * |
26,2
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 69,84% |
Dernier transcript sur Iqvia Holdings Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03/10/16 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 01/08/20 |
James Berkshire
COO | Chief Operating Officer | 51 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 03/10/16 |
Colleen Goggins
BRD | Director/Board Member | 68 | 27/07/17 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03/10/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,08% | 48,16 Md | |
+43,45% | 41,03 Md | |
-5,26% | 28,77 Md | |
+10,11% | 25,59 Md | |
-22,89% | 18,96 Md | |
+7,94% | 12,92 Md | |
+29,01% | 12,03 Md | |
-1,89% | 11,77 Md | |
+21,55% | 11,73 Md |